The "Lignin - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.
New Delhi, Dec 1 (PTI) The government is taking a number of initiatives, including making all government websites available in Indian languages, to promote the use of Indic languages on the internet, Ministry of Electronics and Information Technology (Meity) Secretary Ajay Prakash Sawhney said on Tuesday.
Hamas's Gaza leader, Yehya Al-Sinwar, has tested positive for COVID-19, a spokesman for the Islamist militant group, which runs the Palestinian territory, said on Tuesday. Sinwar, 58, is "following the advice of health authorities and taking precautionary measures", spokesman Hazem Qassem said, without disclosing whether the Hamas chief was in quarantine. Sinwar, a former head of Hamas's security apparatus, became the movement's Gaza leader in 2017, six years after he was freed in a prisoner swap with Israel after more than 20 years in jail.
The digital currency has traded as high as $19,920.53, beating a record set in December 2017.
Mumbai, Dec 1 (PTI) Music maestro A R Rahman says he was lucky enough to have some of the best mentors in his career and now he wants to extend the same help to budding talent from India as the ambassador of BAFTA’s ‘Breakthrough Initiative’.
New Delhi [India], December 1 (ANI): The Supreme Court on Tuesday slammed the Gujarat government for its attempts to allegedly suppress facts regarding the fire in the intensive care unit (ICU) of a private hospital in Rajkot, which led to the death of five COVID-19 patients.
Advanced Energy Industries, Inc. (NASDAQ: AEIS), a global leader in highly engineered, precision power conversion, measurement and control solutions, announced today that the company will host a Virtual Investor Briefing on Monday, December 14, beginning at 4:30 p.m. Eastern Time. During the event, President and CEO Yuval Wasserman and other senior managers will provide an update on the company’s strategic growth initiatives, a detailed review of our Data Center Computing and Industrial & Medical markets, and an update to our long-term financial goals.
The "Animal Wound Care Market - Growth, Trends, and Forecasts (2020 - 2025)" report has been added to ResearchAndMarkets.com's offering.
Aurangabad, Dec 1 (PTI) Ahead of Uttar Pradesh Chief Minister Yogi Adityanath's meeting with film personalities in Mumbai, senior Congress leader and Maharashtra PWD Minister Ashok Chavan on Tuesday alleged the BJP was scheming to take away a slice of Bollywood to the northern state.
Mumbai, Dec 1 (PTI) The rupee surged 37 paise to settle at 73.68 against the US dollar on Tuesday, buoyed by foreign fund inflows into domestic equities.
Kochi, Dec 1 (PTI) As part of the initial phase of the vessel building process, the steel cutting ceremony of the Anti-Submarine Warfare Shallow Water Crafts (ASWSWCs) for the Indian Navy was held on Tuesday at the Cochin Shipyard Limited here.
Watch archived performances from the likes of Olivia Colman
The resumption and opening up of suburban trains has been a huge relief for daily commuters, but continued vigilance on the part of the authorities as well as fellow travellers will go a long way in ensuring safety and building trust
Child-friendly cities to visit before they grow up From Prima
Veterinary Diagnostic Equipment Market Research Report by Testings Type (Bacteriology, Clinical Chemistry Test, Diagnostic Imaging, Hematology, and Immunoassays), by Product Type (Consumables, Reagents & Kits and Instruments & Devices), by Species, by End-User - Global Forecast to 2025 - Cumulative Impact of COVID-19New York, Dec. 01, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Veterinary Diagnostic Equipment Market Research Report by Testings Type, by Product Type, by Species, by End-User - Global Forecast to 2025 - Cumulative Impact of COVID-19" - https://www.reportlinker.com/p05993428/?utm_source=GNW The Global Veterinary Diagnostic Equipment Market is expected to grow from USD 2,246.97 Million in 2019 to USD 3,588.64 Million by the end of 2025 at a Compound Annual Growth Rate (CAGR) of 8.11%. Market Segmentation & Coverage: This research report categorizes the Veterinary Diagnostic Equipment to forecast the revenues and analyze the trends in each of the following sub-markets: Based on Testings Type, the Veterinary Diagnostic Equipment Market studied across Bacteriology, Clinical Chemistry Test, Diagnostic Imaging, Hematology, Immunoassays, Molecular Testing, Parasitology, Pathology, Serology, and Virology. Based on Product Type, the Veterinary Diagnostic Equipment Market studied across Consumables, Reagents & Kits and Instruments & Devices. Based on Species, the Veterinary Diagnostic Equipment Market studied across Avian, Bovine, Camelid, Canine & Feline, Caprine, Equine, Ovine, and Porcine. Based on End-User, the Veterinary Diagnostic Equipment Market studied across Hospitals & Clinics, Point-of-Care/In-House Testing, Reference Laboratories, and Research Centers & Universities. Based on Geography, the Veterinary Diagnostic Equipment Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom. Company Usability Profiles: The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Veterinary Diagnostic Equipment Market including Abaxis, Inc, Agfa-Gevaert N.V., Agrolabo SPA, BCF Technology India Pvt. Ltd, BioChek B.V., Biomérieux SA, Carestream Health, Diagnostic Imaging Systems, Henry Schein, Inc, Heska Corporation, IDEXX Laboratories, Inc., IDvet, IM3 Inc, INDICAL Bioscience GmbH, Merck & Co., Inc., Mindray Medical International Ltd., MinXray, Inc., Neogen Corporation, Qiagen N.V., Randox Laboratories, Ltd., Sedecal, Thermo Fisher Scientific, Inc, Virbac, and Zoetis, Inc.. FPNV Positioning Matrix: The FPNV Positioning Matrix evaluates and categorizes the vendors in the Veterinary Diagnostic Equipment Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape. Competitive Strategic Window: The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth. Cumulative Impact of COVID-19: COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market. The report provides insights on the following pointers: 1\. Market Penetration: Provides comprehensive information on the market offered by the key players 2\. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets 3\. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments 4\. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players 5\. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments The report answers questions such as: 1\. What is the market size and forecast of the Global Veterinary Diagnostic Equipment Market? 2\. What are the inhibiting factors and impact of COVID-19 shaping the Global Veterinary Diagnostic Equipment Market during the forecast period? 3\. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Veterinary Diagnostic Equipment Market? 4\. What is the competitive strategic window for opportunities in the Global Veterinary Diagnostic Equipment Market? 5\. What are the technology trends and regulatory frameworks in the Global Veterinary Diagnostic Equipment Market? 6\. What are the modes and strategic moves considered suitable for entering the Global Veterinary Diagnostic Equipment Market? Read the full report: https://www.reportlinker.com/p05993428/?utm_source=GNW About Reportlinker ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place. __________________________ CONTACT: Clare: email@example.com US: (339)-368-6001 Intl: +1 339-368-6001
Every Premier League fixture for the 2020/21 season plus confirmed dates and kick-off times
António Horta-Osório has been appointed the next chair of Credit Suisse and will leave Lloyds next April to take up the role.
FORM 8.3PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”)1. KEY INFORMATION(a) Full name of discloser:Rathbone Brothers PLC (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. (c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offereeUrban & Civic Plc (d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: (e) Date position held/dealing undertaken: For an opening position disclosure, state the latest practicable date prior to the disclosure30/11/2020 (f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer? If it is a cash offer or possible cash offer, state “N/A”No 2. POSITIONS OF THE PERSON MAKING THE DISCLOSUREIf there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)Class of relevant security: InterestsShort positions Number%Number% (1) Relevant securities owned and/or controlled:3,231,8312.2260% (2) Cash-settled derivatives: (3) Stock-settled derivatives (including options) and agreements to purchase/sell: TOTAL:3,231,8312.2260% All interests and all short positions should be disclosed.Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).(b) Rights to subscribe for new securities (including directors’ and other employee options)Class of relevant security in relation to which subscription right exists: Details, including nature of the rights concerned and relevant percentages: 3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSUREWhere there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.The currency of all prices and other monetary amounts should be stated.(a) Purchases and salesClass of relevant securityPurchase/sale Number of securitiesPrice per unit 1p Ordinary Shares Sale 5,0003.435p (b) Cash-settled derivative transactionsClass of relevant securityProduct description e.g. CFDNature of dealing e.g. opening/closing a long/short position, increasing/reducing a long/short positionNumber of reference securitiesPrice per unit (c) Stock-settled derivative transactions (including options)(i) Writing, selling, purchasing or varyingClass of relevant securityProduct description e.g. call optionWriting, purchasing, selling, varying etc.Number of securities to which option relatesExercise price per unitType e.g. American, European etc.Expiry dateOption money paid/ received per unit (ii) ExerciseClass of relevant securityProduct description e.g. call optionExercising/ exercised againstNumber of securitiesExercise price per unit (d) Other dealings (including subscribing for new securities)Class of relevant securityNature of dealing e.g. subscription, conversionDetailsPrice per unit (if applicable) 4. OTHER INFORMATION(a) Indemnity and other dealing arrangementsDetails of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer: Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none” (b) Agreements, arrangements or understandings relating to options or derivativesDetails of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to: (i) the voting rights of any relevant securities under any option; or (ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced: If there are no such agreements, arrangements or understandings, state “none” (c) AttachmentsIs a Supplemental Form 8 (Open Positions) attached?No Date of disclosure:01/12/2020 Contact name:Angela Hepburn – Compliance Department Telephone number:0151 236 6666 Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.
Sure, you love Emma Thompson. But what about Sophie?From Redbook
Follow the latest updates